av/larimar-therapeutics--big.svg

COM:LARIMARTX

Larimar Therapeutics

  • Stock

Last Close

6.08

21/11 18:19

Market Cap

584.11M

Beta: -

Volume Today

450.09K

Avg: -

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. The company is based in Bala Cynwy...Show More

peer of

investor of